Psychological impact of predicting individuals' risks of illness: A systematic review

Social Science and Medicine

Volumn 49, Issue 12, 1999, Pages 1571-1598

  Shaw, Chris ^a   Abrams, Keith ^a   Marteau, Theresa M ^b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Psychological impact; Risk assessment; Screening

Indexed keywords

ANXIETY; CLINICAL TRIAL; DEPRESSION; DISTRESS SYNDROME; HUMAN; META ANALYSIS; METHODOLOGY; MOOD; PSYCHOLOGIC ASSESSMENT; REVIEW; RISK ASSESSMENT; SCREENING; STATISTICS;

EID: 0032821414     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0277-9536(99)00244-0     Document Type: Article

References (82)

1. Abe, K., Itoyama, Y., 1997. Psychological consequences of genetic testing for spinocerebellar ataxia in the Japanese. European Journal of Neurology 4, 593-600.
2. Abrams, K.R., Lambert, P.C., Sanso, B., Shaw, C., Marteau, T., 1999. Meta-analysis of heterogenously reported study results - A Bayesian approach. In: Berry, D., Stangl, D. (Eds.), Developments in Meta-analysis. Dekker, New York in press.
3. Ambrosio, G.B., Dissegna, L., Zamboni, S., Santonastaso, P., Canton, G., Dal, Palu C., 1984. Psychological effects of hypertension labeling during a community survey. A two-year follow-up. Journal of Hypertension 2, 171-173.
4. Ameling, E.H., de Korte, D.F., Man in't, Veld A.J., 1991. Impact of diagnosis and treatment of hypertension on quality of life: A double-blind, randomized placebo-controlled, cross-over study of betaxolol. Journal of Cardiovascular Pharmacology 18, 752-760.
5. Antoni, M.H., Baggett, L., Ironson, G., LaPerriere, A., August, S., Klimas, N., Schneiderman, N., Fletcher, M.A., 1991. Cognitive-behavioral stress management intervention buffers distress responses and immunologic changes following notification of HIV-1 seropositivity. Journal of Consulting and Clinical Psychology 59, 906-915.
6. Benfari, R.C., Eaker, E., McIntyre, K., Oglesby, P., 1980. Risk factor screening and intervention: A psychosocial/ behavioural cost or a benefit? Controlled Clinical Trials 2, 3-14.
7. Bennett, Johnson S., Riley, W., Hansen, C.A., Nurick, M.A., 1990. Psychological impact of islet cell-antibody screening. Diabetes Care 13, 93-97.
8. Bennett, Johnson S., Tercyak, K.P., 1995. Psychological impact of islet cell antibody screening for IDDM on children, adults, and their family members. Diabetes Care 18, 1370-1372.
9. Bloom, J.R., Monterossa, S., 1981. Hypertension labeling and sense of well-being. American Journal of Public Health 71, 1228-1232.
10. Brandt, J., Quaid, K., Folstein, S.E., Garber, P., Maestri, N.E., Abbott, M.H., Slavney, P.R., Franz, M.L., Kasch, L., Kazazian, H.H., 1989. Presymptomatic diagnosis of delayed-onset disease with linked DNA markers. Journal of the American Medical Association 261, 3108-3114.
11. Chalmers, I., Altman, D.G., 1995. Systematic Reviews. BMJ Publishing Group, London.
12. Charlson, M.E., Alderman, M., Melcher, L., 1982. Absenteeism and labelling in hypertensive subjects: Prevention of an adverse impact in those at high risk. The American Journal of Medicine 73, 165-170.
13. Codori, A., Slavney, P.R., Young, C., Miglioretti, D.L., Brandt, J., 1997. Predictors of psychological adjustment to genetic testing for Huntington's disease. Health Psychology 16 (1), 36-50.
14. Croyle, R.T. (Ed.), 1995. Psychological Effects of Screening for Disease Prevention and Detection. Oxford University Press, New York.
15. Croyle, R.T., Smith, K.R., Botkin, J.R., Baty, B., Nash, J., 1997. Psychological responses to BRCA1 mutation testing: preliminary findings. Health Psychology 16 (1), 63-72.
16. Department, of Health, 1995. The Genetics of Common Diseases: A Second Report to the NHS Central Research and Development Committee on the new genetics. HMSO, London.
17. Fischer, P.M., Guinan, K.H., Burke, J.J., Karp, W.B., Richards, J.W., 1990. Impact of a public cholesterol screening program. Archives of Internal Medicine 150, 2567-2572.
18. Fleiss, J.L., 1993. Statistical basis for meta-analysis. Statistical Methods in Medical Research 2, 121-145.
19. Hall, S., Bobrow, M., Marteau, T.M., 1997. Parents' attributions of blame for the birth of a child with Down syndrome: a pilot study. Psychology and Health 12, 579-587.
20. Havas, S., Reisman, J., Hsu, L., Koumjian, L., 1991. Does cholesterol screening result in negative labeling effects? Archives of Internal Medicine 151, 113-119.
21. Haynes, R.B., Sackett, D.L., Taylor, W., Gibson, E.S., Johnson, A.L., 1978. Increased absenteeism from work after detection and labeling of hypertensive patients. New England Journal of Medicine 299, 41-744.
22. Holland, W.W., Stewart, S., 1990. Screening in Health Care. Nuffield Provincial Hospitals Trust, London.
23. Hornsby, J.L., Sappington, J.T., Mongan, P., Gullen, W.H., Bono, S.F., Altekruse, E., 1985. Risk for bladder cancer: psychological impact of notification. Journal of the American Medical Association 253, 1899-1902.
24. Houts, P.S., McDougall, V., 1988. Effects of informing workers of their health risks from exposure to toxic materials. American Journal of Industrial Medicine 13, 271-279.
25. Huggins, J., Elman, N., Baker, C., Forrester, R.G., Lyter, D., 1991. Affective and behavioural responses of gay and bisexual men to HIV antibody testing. Social Work 36, 61-66.
26. Ironson, G., LaPerriere, A., Antoni, M., O'Hearn, P., Schneiderman, N., Klimas, N., Fletcher, M.A., 1990. Changes in immune and psychological measures as a function of anticipation and reaction to news of HIV-1 antibody status. Psychosomatic Medicine 52, 247-270.
27. Irvine, M.J., Garner, D.M., Olmsted, M.P., Logan, A.G., 1989. Personality differences between hypertensive and normotensive individuals: influence of knowledge of hypertension status. Psychosomatic Medicine 51, 537-549.
28. Jadresic, D., Riccio, M., Hawkins, D.A., Wilson, B., Shanson, D.C., Thompson, C., 1994. Long-term impact of HIV diagnosis on mood and substance use - St Stephen's cohort study. International Journal of STD and AIDS 5, 248-252.
29. Johnston, M.E., Gibson, E.S., Terry, C.W., Haynes, R.B., Taylor, D.W., Gafni, A., Sicurella, J., Sackett, D.L., 1984. Effects of labeling on income, work, and social function among hypertensive employees. Journal of Chronic Diseases 37, 417-423.
30. Johnston, M., Vogele, C., 1993. Benefits of psychological preparation for surgery: A meta-analysis. Annals of Behavioral Medicine 15, 245-256.
31. Kash, K.M., Holland, J.C., Halper, M.S., Miller, D.G., 1992. Psychological distress and surveillance behaviors of women with a family history of breast cancer. Journal of the National Cancer Institute 84, 24-30.
32. Kottke, T.E., Tuomilehto, J., Nissinen, A., Enlund, H., Piha, T., 1987. Hypertension treatment without labeling effects: the North Karelia Project. Journal of Human Hypertension 1, 185-194.
33. LaPerriere, A.R., Antoni, M., Schneiderman, N., Ironson, G., Klimas, N., Caralis, P., Fletcher, M.A., 1990. Exercise intervention attenuates emotional distress and natural killer cell decrements following notification of positive serologic status for HIV-1. Biofeedback and Self-Regulation 15, 229-242.
34. Lawson, K., Wiggins, S., Green, T., Adam, S., Bloch, M., Hayden, M.R., The Canadian Collaborative Study of Predictive Testing, 1996. Adverse psychological events occurring in the first year after predictive testing for Huntington's disease. Journal of Medical Genetics 33, 856-862.
35. Lebovits, A.H., Byrne, M., Strain, J.J., 1986. The case of asbestos exposed workers: a psychological evaluation. In: Lebovits, A.H., Baum, A., Singer, J. (Eds.), Advances in environmental psychology Vol. 6: Exposure to hazardous substances: psychological parameters. Erlbaum, Hillsdale New Jersey, pp. 3-17.
36. Lerman, C., Croyle, R.T., 1995. Genetic testing for cancer predisposition: Behavioural science issues. Journal of the National Cancer Institute Monographs 17, 63-66.
37. Lerman, C., Daly, M., Sands, C., Balshem, A., Lustbader, E., Heggan, T., Goldstein, L., James, J., Engstrom, P., 1993. Mammography adherence and psychological distress among women at risk for breast cancer. Journal of the National Cancer Institute 85, 1074-1080.
38. Lerman, C., Miller, S.M., Scarborough, R., Janjani, P.M., Nolte, S., Smith, D., 1991. Adverse psychological consequences of positive cervical screening. American Journal of Obstetrics and Gynecology 165, 658-662.
39. Lerman, C., Narod, S., Schulman, K., Hughes, C., Gomez-Caminero, A., Bonney, G., Gold, K., Trock, B., Main, D., Lynch, J., Fulmore, C., Snyder, C., Lemon, S.J., Conway, T., Tonin, P., Lenoir, G., Lynch, H., 1996. BRCA1 testing in families with hereditary breast-ovarian cancer: a prospective study of patient decision making and outcomes. Journal of the American Medical Association 275, 1885-1892.
40. Mann, A.H., 1977. The psychological effect of a screening programme and clinical trial for hypertension upon the participants. Psychological Medicine 7, 431-438.
41. Marteau, T.M., 1993. Health related screening: Psychological predictors of uptake and impact. In: Maes, S., Leventhal, H., Johnston, M. (Eds.), International Review of Health Psychology, vol. vol. 2. Wiley, Chichester, pp. 149-174.
42. Marteau, T.M., 1995. Towards an Understanding of the Psychological Consequences of Screening. In: Croyle, R.T. (Ed.), Psychosocial Effects of Screening for Disease Prevention and Detection. Oxford University Press, New York, pp. 185-199.
43. Marteau, T.M., Croyle, R.T., 1998. Psychological responses to genetic testing. British Medical Journal 316, 693-696.
44. Marteau, T.M., Dundas, R., Axworthy, D., 1997. Long term cognitive and emotional impact of genetic testing for carriers of cystic fibrosis: the effects of gender and test result. Health Psychology 16, 51-62.
45. Michie, S., Marteau, T.M., 1996. Predictive genetic testing in children: the need for psychological research. British Journal of Health Psychology 1, 3-14.
46. Milne, B., Logan, A.G., Flanagan, P.T., 1985. Alterations in health perception and life-style in treated hypertensives. Journal of Chronic Disease 38, 37-45.
47. Monk, M., 1981. Blood pressure awareness and psychological well-being in the health and nutrition examination survey. Clinical and Investigative Medicine 4, 183-189.
48. Moum, T., Naess, S., Sorensen, T., Tambs, K., Homen, J., 1990. Hypertension labelling, life events and psychological well-being. Psychological Medicine 20, 635-646.
49. Myers, J.R., Henderson-King, D.H., Henderson-King, E.I., 1997. Facing technological risks: the importance of individual differences. Journal of Research in Personality 31, 1-20.
50. Ostrow, D.G., Joseph, J.G., Kessler, R., Soucy, J., Tal, M., Eller, M., Chmiel, J., Phair, J.P., 1989. Disclosure of HIV antibody status: Behavioral and mental health correlates. AIDS Education and Prevention 1, 1-11.
51. Perry, S., Fishman, B., Jacobsberg, L., Young, J., Frances, A., 1991. Effectiveness of psychoeducational interventions in reducing emotional distress after human immunodeficiency virus antibody testing. Archives of General Psychiatry 48, 143-147.
52. Perry, S., Jacobsberg, L., Card, C.A.L., Ashman, T., Frances, A., Fishman, B., 1993. Severity of psychiatric symptoms after HIV testing. American Journal of Psychiatry 150, 775-779.
53. Perry, S.W., Jacobsberg, L.B., Fishman, B., Weiler, P.H., Gold, J.W.M., Frances, A.J., 1989. Psychological responses to serological testing for HIV. AIDS 4, 145-152.
54. Petticrew, M., Sowden, A., Lister-Sharp, D. False negatives in screening programmes: impact and implications. Health Technology Assessment (in press).
55. Polk, B.F., Harlan, L.C., Cooper, S.P., Stromer, M., Ignatius, J., Mull, H., Blaszkowski, M., 1984. Disability days associated with detection and treatment in a hypertension control program. American Journal of Epidemiology 119, 44-53.
56. Pugh, K., Riccio, M., Jadresic, D., Burgess, A.P., Baldeweg, T., Catalan, J., Lovett, E., Hawkins, D.A., Gruzelier, J., Thompson, C., 1994. A longitudinal study of the neuropsychiatric consequences of HIV-1 infection in gay men. II Psychological and health status at baseline and at 12-month follow-up. Psychological Medicine 24, 897-904.
57. Quaid, K.A., Wesson, M., 1995. Exploration of the effects of predictive testing for Huntington disease on intimate relationships. American Journal of Medical Genetics 57, 46-51.
58. Rastam, L., Ryden, L., 1987. Work absenteeism and well-being in patients treated for hypertension. European Heart Journal 8, 1024-1031.
59. Reelick, N.F., De Haes, W.F.M., Schuurman, J.H., 1984. Psychological side-effects of the mass screening on cervical cancer. Social Science and Medicine 18, 1089-1093.
60. Rimes, K.A., Salkovskis, P.M., Shipman, A.J., 1999. Psychological and behavioural effects of bone density screening for osteoporosis. Psychology and Health 14, 567-590.
61. Rudd, P., Price, M.G., Graham, L.E., Beilstein, B.A., Tarbell, S.J.H., Bacchetti, P., Fortmann, S.P., 1986. Consequences of worksite hypertension screening: differential changes in psychosocial function. The American Journal of Medicine 80, 853-860.
62. Rudd, P., Price, M.G., Graham, L.E., Beilstein, B.A., Tarbell, S.J.H., Bacchetti, P., Fortmann, S.P., 1987. Consequences of worksite hypertension screening: changes in absenteeism. Hypertension 10, 425-435.
63. Sackett, D.L., Haynes, R.B., Guyatt, G.H., Tugwell, P., 1991. Clinical Epidemiology: A basic science for clinical medicine, 2nd ed. Little, Brown, Toronto.
64. Salkovskis, P.M., Clark, D.M., 1993. Panic disorders and hypochondriasis. Advances in Behavioural Research Therapy 15, 23-48.
65. Sands, R.G., Newby, L.G., Greenberg, R.A., 1981. Labeling of health risk in industrial settings. The Journal of Applied Behavioral Science 17, 359-374.
66. Soghikian, K., Fallick-Hunkeler, E.M., Ury, H.K., Fisher, A.A., 1981. The effect of high blood pressure awareness and treatment on emotional well-being. Clinical and Investigative Medicine 4, 191-196.
67. Stewart, D.E., Lickrish, G.M., Sierra, S., Parkin, H., 1993. The effect of educational brochures on knowledge and emotional distress in women with abnormal papanicolaou smears. Obstetrics and Gynecology 81, 280-282.
68. Stoate, H.G., 1989. Can health screening damage your health? Journal of the Royal College of General Practitioners 39, 193-195.
69. Taylor, D.W., Haynes, R.B., Sackett, D.L., Gibson, E.S., 1981. Longterm follow-up of absenteesim among working men following the detection and treatment of their hypertension. Clinical and Investigative Medicine 4, 173-177.
70. Taylor, C.A., Myers, R.H., 1997. Long-term impact of Huntington disease linkage testing. American Journal of Medical Genetics 70, 365-370.
71. Thompson, S.G., 1994. Why sources of heterogeneity in meta-analysis should be investigated. British Medical Journal 309, 1351-1355.
72. Tibben, A., Duivenvoorden, H.J., Niermeijer, M.F., Vegter-van der Vlis, M., Roos, R.A.C., Roojimans, H.G.M., Verhage, F., 1994. Psychological effects of presymptomatic DNA testing for Huntington's disease in the Dutch program. Psychosomatic Medicine 56, 526-532.
73. Tibben, A., Frets, P.G., van de Kamp, J.J.P., Niermeijer, M.F., der Vlis, M.V., Roos, R.A.C., Rooymans, H.G.M., van Ommen, G-J.B., Verhage, F., 1993. On attitudes and appreciation 6 months after predictive DNA testing for Huntington disease in the Dutch programme. American Journal of Medical Genetics 48, 103-111.
74. Tibben, A., Timman, R., Bannink, E.C., Duivenvoorden, H.J., 1997. Three-year follow-up after presymptomatic testing for Huntington's disease in tested individuals and partners. Health Psychology 16 (1), 20-35.
75. Tibben, A., Vegter-van der Vlis, M., Skraastad, M.I., Frets, P.G., van de Kamp, J.J.P., Niermeijer, M.F., van Ommen, G.J.B., Roos, R.A.C., Roojimans, H.G.M., Stronks, D., Verhage, F., 1992. DNA-testing for Huntington's disease in The Netherlands; a retrospective study on psychosocial effects. American Journal of Medical Genetics 44, 94-99.
76. Torgerson, D.J., Thomas, R.E., Campbell, M.K., Reid, D.M., 1997. Randomized trial of osteoporosis screening: use of hormone replacement therapy and quality of life results. Archives of Internal Medicine 157, 2121-2125.
77. Tymstra, T.J., Bieleman, B., 1987. The psychosocial impact of mass screening for cardiovascular risk factors. Family Practice 4, 287-290.
78. Wardle, F.J., Collins, W., Pernet, A.L., Whitehead, M.I., Bourne, T.H., Campbell, S., 1993. Psychological impact of screening for familial ovarian cancer. Journal of the National Cancer Institute 85, 653-657.
79. Wardle, J., Pernet, A., Stephens, D., 1995. Psychological consequences of positive results in cervical cancer screening. Psychology and Health 10, 195-204.
80. Wiggins, S., Whyte, P., Huggins, M., Adam, S., Theilmann, J., Bloch, M., Sheps, S.B., Schechter, M.T., Hayden, M.R., 1992. The psychological consequences of predictive testing for Huntington's disease. The New England Journal of Medicine 20, 1401-1405.
81. Wilkinson, C., Jones, J.M., McBride, J., 1990. Anxiety caused by abnormal result of cervical smear test: a controlled trial. Brtish Medical Journal 300, 440.
82. Zonderman, A.B., Leu, V.L., Costa, P.T., 1986. Effects of age, hypertension history, and neuroticism on health perceptions. Experimental Gerontology 21, 449-458.